Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma

Journal of Investigative Dermatology

Volumn 115, Issue 1, 2000, Pages 62-65

  Väkevä, Liisa ^a   Pukkala, Eero ^b   Ranki, Annamari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Lung cancer; Mycosis fungoides; Non Hodgkin lymphoma; Small cell lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; FEMALE; FINLAND; FOLLOW UP; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0033940661     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00011.x     Document Type: Article

References (34)

1. Adjei AA, Marks RS, Bonner JA: Current guidelines for the management of small cell lung cancer. Mayo Clinic Proc 74:809-816, 1999
2. Armstrong BK, Kricker A, Tan E, Yamasaki H, English DE: UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer I 90:523-531, 1998
3. Brousset P, Lamant L, Viraben R, et al: Hodgkin's disease following mycosis fungoides: phenotypic and molecular evidence for different tumour cell clones. J Clin Pathol 49:504-507, 1996
4. Chan WC, Griem ML, Grozea PN, Freel RJ, Variakojis D: Mycosis fungoides and Hodgkin's disease occurring in the same patient: report of three cases. Cancer 44:1408-1413, 1979
5. Diamandidou E, Cohen PR, Kurzrock R: Mycosis fungoides and Sézary syndrome. Blood 88:2385-2409, 1996
6. Eskenasy A: Arguments for a histogenetic classification of lung carcinomas. Morphol Embryol (Bucur) 27:311-325, 1981
7. Eskenasy A: The microcellular (oat cell, small cell anaplastic) carcinoma of the lung. A histopathological study of 620 diagnosed cases. Morphol Embryol (Bucur) 32:257-269, 1986
8. Finnish Cancer Registry Database 1999, The Finnish Cancer Registry.
9. Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J: Psoriasis, its treatment and cancer in a cohort of Finnish patients. J Invest Dermatol 114: 587-590, 2000.
10. Harland CC, Whittaker SJ, Ng YL, Holden CA, Wong E, Smith NP: Coexistent cutaneous T-cell lymphoma and B-cell chronic lymphocytic leukaemia. Br J Dermatol 127:519-523, 1992
11. Hartge P, Devesa S, Fraumeni JF. Hodgkin's and non-Hodgkin's lymphomas. In: Doll R, Fraumeni JF, Muir CS (eds). Trends in Cancer Incidence and Mortality. New York: Cold Spring Harbor Laboratory Press, 1994, pp 423-453
12. Henseler T, Christophers E, Hönigsmann H, Wolff K: Skin tumors in the European PUVA Study, eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 16:108-116, 1987
13. Kantor AF, Curtis RE, van Vonderheid EC, Scott EJ, Fraumeni JF Jr: Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 63:1612-1615, 1989
14. Karenko L, Kahkonen M, Hyytinen E, Lindlof M, Ranki A: Notable losses at specific regions of chromosomes 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 112:392-395, 1999
15. Kripke ML: Ultraviolet radiation and immunology: Something new under the sun. Cancer Res 54:6102-6105, 1994
16. de Leij L, Poppema S, Nulend JK, et al: The TH Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res 45:2192-2200, 1985
17. Lindelof B, Sigurgeirsson B, Tegner E, et al: PUVA and cancer: a large-scale epidemiological study. Lancet 338:91-93, 1991
18. Manns A, Hisada M, La grenade L. Human T-lymphotrophic virus type I infection. Lancet 353:1951-1958, 1999
19. McGregor JM, Crook T, Fraser-Andrews EA, et al: SJ. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas. J Invest Dermatol 112:317-321, 1999
20. McMichael JA, Bonett A, Roder D: Cancer incidence among migrant populations in South Australia. Med J Aust 150:417-420, 1989
21. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA: Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291:207-211, 1974
22. Petersen I, Langreck H, Wolf G, et al: Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75:79-86, 1997
23. Pukkala E. Use of record linkage in small area studies. In: Elliot B, Guzick J, English D, Stern R (eds). Geographical and Environmental Epidemiology. Oxford: Oxford University Press, 1992, pp 125-131
24. Pukkala E. Cancer risk by social class and occupation. A survey of 109,000 cancer cases among Finns of working age. In: Wahrendorf J (ed.), Contributions to Epidemiology and Biostatistics, Vol. 7. Heidelberg: Karger, 1995
25. Ranki A, Niemi K-M, Nieminen P, Krohn K: Antibodies against retroviral core proteins in relation to disease outcome in patients with mycosis fungoides. Arch Dermatol Res 282:532-538, 1990
26. Sandbank M, Katzenellenbogen I: Mycosis fungoides of prolonged duration in siblings. Arch Dermatol 98:620, 1968
27. Sethi T, Rintoul RC, Moore SM, et al: Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5 (6):662-668, 1999
28. Stern RS, Laird N: The carcinogenic risk of treatments for severe psoriasis: photochemotherapy follow-up study. Cancer 73:2759-2764, 1994
29. Stern RS, Väkevä LH, and the PUVA Follow-up Study: Noncutaneous malignant tumors in the PUVA follow-up study 1975-96. J Invest Dermatol 108:897-900, 1997
30. Stern RS, Nichols KT, Väkevä L: Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet a radiation (PUVA). N Engl J Med 336:1041-1045, 1997
31. Teppo L, Pukkala E, Lehtonen M: Data quality and quality control of a population- based cancer registry. Experience in Finland. Acta Oncol 33:365-369, 1994
32. Weinstock MA, Horn JW: Mycosis fungoides in the United States - Increasing incidence and descriptive epidemiology. JAMA 260:42, 1988
33. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371, 1997
34. Williams CL: Basis science of small cell lung cancer. Chest Surg Clin N Am 7:1-19, 1997